A division of Dosage Form Solutions
Encap’s team has extensive experience within the life sciences industries ranging from start-ups to multinational companies.
The team has a complementary combination of scientific and business skills covering research, development, manufacturing, cGMP, analytical chemistry, high containment production, project management, marketing, intellectual property, technology, product licensing and finance.
Stephen obtained a Pharmacy degree from the Queen's University of Belfast in 1979 and an MSc in Pharmaceutical Sciences from the University of Sunderland in 1986. He joined Sterling Winthrop in 1986 as a Formulation Scientist and over the following years held a number of positions in R&D, Technical Services and commercial manufacturing support in the UK and the US organization. Following the divestment of Sterling Winthrop by Kodak in 1994 he joined the Sanofi Research organization as a Research Leader in the Pharmaceutical Sciences Department. Stephen obtained a PhD on the modification of hydrophobic drug crystals from the University of Sunderland in 1996 under the supervision of Professor Geoff Rowley. In 1996 he joined Chiroscience in the UK as Head of Formulation and was subsequently promoted to Head of Pharmaceutical Sciences. Stephen continued in this role for the combined organisation following the acquisition of Chiroscience by Celltech in 1999. During the course of his career he has been involved in the development and commercialization of a number of drug products and drug delivery technologies and has been responsible for a number of successful patent filings. Immediately prior to joining Encap Drug Delivery he was Associate Director of Product Technology Development for UCB Celltech.
After a period within academic research, Massoud joined the pharmaceutical industry and became involved in product development, holding senior positions in a variety of areas including clinical trials manufacture (Phase I and II) and Quality Assurance. He joined Encap in 1997 and was appointed as Chief Scientific Officer in 2005. Massoud has over 20 years experience in the pharmaceutical industry and is author/co-author of over 20 scientific papers and over 10 patents. Massoud gained his BSc in Chemistry from Tehran University and holds an MSc in Chemistry from Salford University.
Bill was a co-founder of Encap Drug Delivery in 1989. He had previously spent twelve years as a Development Head within Eli Lilly, where he was responsible for the development of ‘vancomycin capsules', which have become the industry-yardstick for liquid-fill two-piece capsules. He is an acknowledged expert in the technology, with over thirty publications and invited speaker presentations. Bill has extensive experience in formulation and processing of a wide range of liquid-fill capsule products, including licensed and investigative medicinal and in nutraceutical materials. He is a pharmacist and has acted as Technical Director and ‘Qualified Person' since the company's establishment.
David joined Encap in 2004 and has overall responsibility for the Company's Finance, HR, IT and Health & Safety, he also acts as Company Secretary. He has over 20 years financial and business management experience from a diverse range of businesses including the Student Loan Company, Sodexho Limited and Currys plc. David is Chartered Institute of Management Accountants (CIMA) trained.
Jim joined Encap in May 1998 bringing with him seven years of cGMP manufacturing and R&D experience from Johnson & Johnson's Medical Biopolymer Group. Prior to this he spent eight years with R&D at MSA Catalyst and Safety working on various products from lithium alloy missile batteries to KO2 based Respiratory Protective Equipment. Jim's duties at Encap include management of the warehouse and production departments making him responsible for all customer materials from receipt to shipment of finished product - and everything in between. Jim was promoted to Production Director and to Encap's board in 2005.
Jane joined Encap in March 2010 and has over 11 years experience within the Pharmaceutical industry, in both CRO and Biopharmaceutical environments. Jane obtained a degree in Applied Biochemistry in 1994, and then went on to obtain a PhD, both from the University of Paisley. After leaving university Jane worked with Vitrolife for 3 years, before moving to Aptuit (formerly Quintiles), holding positions as Senior Formulation Scientist, Formulation Supervisor, Formulation Development Manager and latterly Director of Pharmaceutics.
Copyright © Encap 2013Web design: Net Resources